News

Elieen, Actual Sientra Patient

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Sientra Announces Launch Of Viality™, A Novel Fat Transfer System December 5, 2022
Sientra Reports Record Third Quarter 2022 Financial Results November 10, 2022
Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022 October 31, 2022
Sientra Announces Pricing of $13.2 Million Public Offering October 21, 2022
Sientra Announces Proposed Public Offering October 18, 2022
Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management October 12, 2022
Sientra Supports Breast Cancer Awareness Month by Launching Educational Programs Designed to Empower Women October 3, 2022
Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia September 20, 2022
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) September 6, 2022
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel August 11, 2022
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022 July 28, 2022
Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation July 11, 2022
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant July 6, 2022
Sientra To Present At The William Blair 42nd Annual Growth Stock Conference May 23, 2022
Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference May 18, 2022
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022 May 12, 2022
Sientra to Report First Quarter 2022 Financial Results on May 12, 2022 May 3, 2022
Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT March 24, 2022
Sientra Receives Regulatory Approval to Market Breast Implants in Canada March 24, 2022
Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021 March 23, 2022
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) March 10, 2022
Sientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022 March 9, 2022
Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues January 10, 2022
Sientra Announces Acquisition of Novel Fat Grafting Technology from AuraGen Aesthetics, LLC January 5, 2022

Nasdaq: SIEN

Stock Quote: NASD

$0.26 +0.00
Volume 232,791
Previous Close 0.25
Intraday High 0.27
Intraday Low 0.24
Pricing delayed 20 minutes
Price Change % Change +1.06% 52 Week High 4.43 52 Week Low 0.16 Today's Open 0.27 Dec 07, 2022 11:25 AM

Email Alerts

Email: *
Subscription Preferences *




 
Enter the code shown above.

Investor Contact

Sientra Investor Relations
ir@sientra.com

© 2021 Sientra, Inc. All rights reserved.